Adding Of Naxitamb In Induction Therapy For High Risk Neuroblastoma — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Adding Of Naxitamb In Induction Therapy For High Risk Neuroblastoma — Stella

Home/Neuroblastoma/

View on ClinicalTrials.gov

Recruiting

Back to Neuroblastoma trials

Trial locations(1 site)

China

Guangzhou Women And Children's Medical Center, Guanzhou, Guangdong

Key details

Sponsor

Guangzhou Women and Children's Medical Center

Enrollment target

~64 participants

Started

May 2024

Primary completion

December 2029

Age range

1 Year – 21 Years

Last updated August 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.